🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ProjectAfrica Day 337-342: Day 337: 70.7km Day 338: 69.8km Day 339: 72.6km Day 340: 28.9km Day 341: 76km Day 342: 74.6km Total raised for charity: £350,537 9 days out. For so long the finish line has felt like some mystical event happening very far into the future so it’s

Russ Cook has crossed the finish line in Tunisia, running the length of Africa - incredible achievement 🙌

The first person ever to run the entire length of Africa. Mission complete🫡

2004 - National University Hospital, Singapore NUS-2024 - #EAU24 . Great catching up with so many friends and making so many more HoYee Tiong Jeremy Teoh Prof. Prokar Dasgupta OBE Prof Asif Muneer mallikarjuna c Jon Aning Prof Param Mariappan FRCS(Urol), PhD Intuitive Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 Philip Charlesworth

83% of men don't know a family history of prostate or even breast cancer increases their #prostatecancer risk according to new research. Former rugby union player @UgoMonye, who lost his father to prostate cancer in 2021, met with GenesisCare patient Andrew to discuss why knowing

All things surgical at the Uro-Oncology session at BAUS 2024! Join the semi-live video session in Hall 4 starting at 11:00. 🎬 #BAUS2024 #UroOncology Amit Mevcha Philip Charlesworth N Ragavan Prof Bhaskar Somani BM Zeeshan Hameed Campbell Tait Ashwin Sridhar Alastair Lamb

Types of urology papers, I can’t stop laughing 😂…

NEWS: FDA 510(k) clearance for HYDROS™ Robotic System - the next-generation, AI-powered platform for BPH now delivers Aquablation® therapy: clinically proven to deliver durable symptom relief while preserving sexual function & continence Learn more 👉: bit.ly/4dO0mDa

HYDROS™ Robotic System deep dive: FirstAssist AI™, built from a library of real-world Aquablation® therapy procedures, uses advanced image recognition software to identify critical anatomy on ultrasound & suggest optimal treatment plan for each patient bit.ly/4fQ3BvJ

Comparing Pneumoperitoneum Pressures for Robotic Cystectomy Outcomes growkudos.com/publications/1… via @growkudos East and North Hertfordshire Teaching NHS Trust Uni of Herts LMS

Important data from our paper - Karel Decaestecker

A key aspect of Sir Chris #Hoy’s sad, brave announcement about his prostate cancer is that his father and grandfather also had it. Systematically testing high risk men as recommended in The Lancet Commission on Prostate Cancer could start now The ICR James N'Dow Vania Wisdom

Late breaking data on 40000 Aquablation procedures 🌍 at #SIU2024NewDelhi 🇮🇳 PROCEPT BioRobotics “Aquablation has been studied in numerous countries and has shown reproducible results regarding safety, efficacy, and durability” 👍 SIU-Urology Philip Charlesworth Jeremy Teoh

'I've asked the NHS to look at the case for lowering the screening age for prostate cancer' Health Secretary Wes Streeting told #BBCBreakfast he will review the rules on testing after Olympic champion Sir Chris Hoy told Sally Nugent the age should be lowered

The WATER IV Prostate Cancer trial is underway and will begin recruitment soon! Visit the newly launched WATER IV PCa website for trial details, eligibility criteria, and a list of participating hospitals: water4pca.com The study is a global multicenter,

Excellent Grand Rounds this morning at USC Urology with Mihir Desai Philip Charlesworth & Brian Helfand MD, PhD on Aquablation and its potential as a prostate cancer treatment.

Retzius-sparing RARP (PPFS) with improved earlier continence in comparison with both standard RARP and anterior hood sparing RARP (APFS). Data from Jim Hu Keith Kowalczyk, MD North American Robotic Urology Society | NARUS #narus2025

Inderbir Gill of USC Urology presented the game changing design of WATER IV PCa at #AUA25: a randomized comparison of whole gland Aquablation and prostatectomy. The outcome could fundamentally change the management of #prostatecancer for many men

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With #BladderCancer jamanetwork.com/journals/jama/… In this randomized clinical trial of 338 patients with nonmetastatic bladder

That’s a wrap on #BAUS25! What an incredible few days in Manchester, where global experts gathered to shape the future of urologic care sharing groundbreaking data, expert insights, and dynamic discussions centered on Aquablation® therapy. A special thank you to our surgeon